| Literature DB >> 35350496 |
Nagapratap Ganta1, Dina Alnabwani1, Veera Jayasree L Bommu1, Sharon Hechter1, Viraj Shah1,2, Pramil Cheriyath1.
Abstract
Statins are a widely prescribed medication that lowers serum cholesterol by inhibiting the HMG-CoA reductase enzyme, a rate-limiting step in cholesterol synthesis. Myopathy is one of the well-known adverse effects of statins, mainly when prescribed with the fibrates. However, statin-induced autoimmune necrotizing myopathy (SIANM) is an infrequent and severe complication. Hence, all clinicians should be more vigilant regarding this complication and treat it early to prevent acute kidney injury (AKI).Entities:
Keywords: anti-hmg co-a reductase antibodies; hypercholesterolemia; hyperlipidemia; immune-mediated necrotizing myopathy; sianm; statin-induced autoimmune necrotizing myopathy; statin-induced myopathy
Year: 2022 PMID: 35350496 PMCID: PMC8933139 DOI: 10.7759/cureus.22273
Source DB: PubMed Journal: Cureus ISSN: 2168-8184